Sep 2026
Senolytic Interventions Enhance the Anti-metastatic Activity of Chemotherapy in Prostate Cancer.
Cellular senescence is a common outcome of cytostatic and cytotoxic cancer therapies. While in some contexts therapy-induced senescence can drive tumor growth suppression and anti-tumor immunity through the senescence-associated secretory phenotype (SASP), in others it can promote metastatic progression and immune supp...
Lin Zhou, Katherine C. Murphy, Hadiya K. Giwa et al.
· Cancer Research · 0 citations